

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001256"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001256" />

    <meta name="citation_title" content="Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells"/>
    <meta itemprop="name" content="Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells"/>

      <meta name="citation_author" content="Hemant Varma"/>
            <meta name="citation_author_institution" content="Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, United States of America"/>
      <meta name="citation_author" content="Andrew J. Skildum"/>
            <meta name="citation_author_institution" content="Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, United States of America"/>
      <meta name="citation_author" content="Susan E. Conrad"/>
            <meta name="citation_author_institution" content="Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, United States of America"/>

    <meta name="citation_date" content="2007/12/5"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001256.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1256"/>
    <meta name="citation_issue" content="12"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Principles of Molecular Medicine;; citation_author=DB Melora; citation_author=CC Allred; citation_author=P O'Conell; citation_number=1; citation_pages=625-632; citation_date=1998; citation_publisher=Humana Press; " />
      <meta name="citation_reference" content="citation_title=Breast cancer adjuvant endocrine therapy.; citation_author=T Cigler; citation_author=PE Goss; citation_journal_title=Cancer journal (Sudbury, Mass); citation_volume=13; citation_number=2; citation_pages=148-155; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice.; citation_author=N Brèunner; citation_author=D Bronzert; citation_author=LL Vindel2v; citation_author=K Rygaard; citation_author=M Spang-Thomsen; citation_journal_title=Cancer research; citation_volume=49; citation_number=3; citation_pages=1515-1520; citation_date=1989; " />
      <meta name="citation_reference" content="citation_title=Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.; citation_author=JS Foster; citation_author=DC Henley; citation_author=A Bukovsky; citation_author=P Seth; citation_author=J Wimalasena; citation_journal_title=Mol Cell Biol; citation_volume=21; citation_number=4; citation_pages=794-810; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E- Cdk2.; citation_author=OW Prall; citation_author=B Sarcevic; citation_author=EA Musgrove; citation_author=CK Watts; citation_author=RL Sutherland; citation_journal_title=J Biol Chem; citation_volume=272; citation_number=5; citation_pages=10882-10894; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen- mediated cell cycle arrest in human breast cancer cells.; citation_author=S Cariou; citation_author=JC Donovan; citation_author=WM Flanagan; citation_author=A Milic; citation_author=N Bhattacharya; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=97; citation_number=6; citation_pages=9042-9046; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=CDK inhibitors: positive and negative regulators of G1-phase progression.; citation_author=CJ Sherr; citation_author=JM Roberts; citation_journal_title=Genes Dev; citation_volume=13; citation_number=7; citation_pages=1501-1512; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=MCF-7: the first hormone-responsive breast cancer cell line.; citation_author=AS Levenson; citation_author=VC Jordan; citation_journal_title=Cancer research; citation_volume=57; citation_number=8; citation_pages=3071-3078; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.; citation_author=M Lippman; citation_author=G Bolan; citation_author=K Huff; citation_journal_title=Cancer Res; citation_volume=36; citation_number=9; citation_pages=4595-4601; citation_date=1976; " />
      <meta name="citation_reference" content="citation_title=Structural rearrangement of the retinoblastoma gene in human breast carcinoma.; citation_author=A T'Ang; citation_author=JM Varley; citation_author=S Chakraborty; citation_author=AL Murphree; citation_author=YK Fung; citation_journal_title=Science; citation_volume=242; citation_number=10; citation_pages=263-266; citation_date=1988; " />
      <meta name="citation_reference" content="citation_title=Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.; citation_author=MD Planas-Silva; citation_author=RA Weinberg; citation_journal_title=Mol Cell Biol; citation_volume=17; citation_number=11; citation_pages=4059-4069; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain.; citation_author=H Varma; citation_author=SE Conrad; citation_journal_title=Oncogene; citation_volume=19; citation_number=12; citation_pages=4746-4753; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.; citation_author=EE Bosco; citation_author=Y Wang; citation_author=H Xu; citation_author=JT Zilfou; citation_author=KE Knudsen; citation_journal_title=J Clin Invest; citation_volume=117; citation_number=13; citation_pages=218-228; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters.; citation_author=EA Dublin; citation_author=NK Patel; citation_author=CE Gillett; citation_author=P Smith; citation_author=G Peters; citation_journal_title=Int J Cancer; citation_volume=79; citation_number=14; citation_pages=71-75; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status.; citation_author=P Jares; citation_author=MJ Rey; citation_author=PL Fernandez; citation_author=E Campo; citation_author=A Nadal; citation_journal_title=J Pathol; citation_volume=182; citation_number=15; citation_pages=160-166; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours.; citation_author=JM Varley; citation_author=J Armour; citation_author=JE Swallow; citation_author=AJ Jeffreys; citation_author=BA Ponder; citation_journal_title=Oncogene; citation_volume=4; citation_number=16; citation_pages=725-729; citation_date=1989; " />
      <meta name="citation_reference" content="citation_title=The retinoblastoma protein and cell cycle control.; citation_author=RA Weinberg; citation_journal_title=Cell; citation_volume=81; citation_number=17; citation_pages=323-330; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Effect of estradiol on human breast cancer cells in culture.; citation_author=P Darbre; citation_author=J Yates; citation_author=S Curtis; citation_author=RJ King; citation_journal_title=Cancer Res; citation_volume=43; citation_number=18; citation_pages=349-354; citation_date=1983; " />
      <meta name="citation_reference" content="citation_title=The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer.; citation_author=I Chu; citation_author=K Blackwell; citation_author=S Chen; citation_author=J Slingerland; citation_journal_title=Cancer research; citation_volume=65; citation_number=19; citation_pages=18-25; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts.; citation_author=M Cheng; citation_author=P Olivier; citation_author=JA Diehl; citation_author=M Fero; citation_author=MF Roussel; citation_journal_title=Embo J; citation_volume=18; citation_number=20; citation_pages=1571-1583; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Cancer cell cycles.; citation_author=CJ Sherr; citation_journal_title=Science (New York, NY); citation_volume=274; citation_number=21; citation_pages=1672-1677; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Association of human cyclin E with a periodic G1-S phase protein kinase.; citation_author=V Duliâc; citation_author=E Lees; citation_author=SI Reed; citation_journal_title=Science (New York, NY); citation_volume=257; citation_number=22; citation_pages=1958-1961; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.; citation_author=CK Osborne; citation_author=DH Boldt; citation_author=P Estrada; citation_journal_title=Cancer research; citation_volume=44; citation_number=23; citation_pages=1433-1439; citation_date=1984; " />
      <meta name="citation_reference" content="citation_title=Polyomavirus T antigens: molecular chaperones for multiprotein complexes.; citation_author=JL Brodsky; citation_author=JM Pipas; citation_journal_title=J Virol; citation_volume=72; citation_number=24; citation_pages=5329-5334; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=RB in breast cancer: at the crossroads of tumorigenesis and treatment.; citation_author=EE Bosco; citation_author=ES Knudsen; citation_journal_title=Cell cycle (Georgetown, Tex); citation_volume=6; citation_number=25; citation_pages=667-671; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.; citation_author=J Lukas; citation_author=D Parry; citation_author=L Aagaard; citation_author=DJ Mann; citation_author=J Bartkova; citation_journal_title=Nature; citation_volume=375; citation_number=26; citation_pages=503-506; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.; citation_author=DJ Mann; citation_author=NC Jones; citation_journal_title=Curr Biol; citation_volume=6; citation_number=27; citation_pages=474-483; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=A pRb-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells.; citation_author=G Camarda; citation_author=F Siepi; citation_author=D Pajalunga; citation_author=C Bernardini; citation_author=R Rossi; citation_journal_title=The Journal of cell biology; citation_volume=167; citation_number=28; citation_pages=417-423; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.; citation_author=E Santoni-Rugiu; citation_author=J Falck; citation_author=N Mailand; citation_author=J Bartek; citation_author=J Lukas; citation_journal_title=Mol Cell Biol; citation_volume=20; citation_number=29; citation_pages=3497-3509; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Living with or without cyclins and cyclin-dependent kinases.; citation_author=CJ Sherr; citation_author=JM Roberts; citation_journal_title=Genes Dev; citation_volume=18; citation_number=30; citation_pages=2699-2711; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1).; citation_author=K Alevizopoulos; citation_author=B Catarin; citation_author=J Vlach; citation_author=B Amati; citation_journal_title=Embo J; citation_volume=17; citation_number=31; citation_pages=5987-5997; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1).; citation_author=X Zhang; citation_author=W Wharton; citation_author=M Donovan; citation_author=D Coppola; citation_author=R Croxton; citation_journal_title=Molecular biology of the cell; citation_volume=11; citation_number=32; citation_pages=2117-2130; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells.; citation_author=S Mukherjee; citation_author=SE Conrad; citation_journal_title=J Biol Chem; citation_volume=280; citation_number=33; citation_pages=17617-17625; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.; citation_author=OW Prall; citation_author=EM Rogan; citation_author=EA Musgrove; citation_author=CK Watts; citation_author=RL Sutherland; citation_journal_title=Mol Cell Biol; citation_volume=18; citation_number=34; citation_pages=4499-4508; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells.; citation_author=AJ Skildum; citation_author=S Mukherjee; citation_author=SE Conrad; citation_journal_title=J Biol Chem; citation_volume=277; citation_number=35; citation_pages=5145-5152; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site.; citation_author=A Schulze; citation_author=K Zerfass; citation_author=D Spitkovsky; citation_author=S Middendorp; citation_author=J Bergáes; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=92; citation_number=36; citation_pages=11264-11268; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Recent progress in the discovery and development of cyclin-dependent kinase inhibitors.; citation_author=PM Fischer; citation_author=A Gianella-Borradori; citation_journal_title=Expert opinion on investigational drugs; citation_volume=14; citation_number=37; citation_pages=457-477; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Genetic analysis of polyomavirus large T nuclear localization: nuclear localization is required for productive association with pRb family members.; citation_author=SH Howes; citation_author=BJ Bockus; citation_author=BS Schaffhausen; citation_journal_title=J Virol; citation_volume=70; citation_number=38; citation_pages=3581-3588; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.; citation_author=H Varma; citation_author=SE Conrad; citation_journal_title=Cancer Res; citation_volume=62; citation_number=39; citation_pages=3985-3991; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=D-type cyclin-dependent kinase activity in mammalian cells.; citation_author=H Matsushime; citation_author=DE Quelle; citation_author=SA Shurtleff; citation_author=M Shibuya; citation_author=CJ Sherr; citation_journal_title=Mol Cell Biol; citation_volume=14; citation_number=40; citation_pages=2066-2076; citation_date=1994; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001256" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells"/>
    <meta name="twitter:description" content="Estrogens are required for the proliferation of hormone dependent breast cancer cells, making estrogen receptor (ER) positive tumors amenable to endocrine therapies such as antiestrogens. However, resistance to these agents remains a significant cause of treatment failure. We previously demonstrated that inactivation of the retinoblastoma protein (pRb) family tumor suppressors causes antiestrogen resistance in MCF-7 cells, a widely studied model of estrogen responsive human breast cancers. In this study, we investigate the mechanism by which pRb inactivation leads to antiestrogen resistance. Cdk4 and cdk2 are two key cell cycle regulators that can phosphorylate and inactivate pRb, therefore we tested whether these kinases are required in cells lacking pRb function. pRb family members were inactivated in MCF-7 cells by expressing polyomavirus large tumor antigen (PyLT), and cdk activity was inhibited using the cdk inhibitors p16INK4A and p21Waf1/Cip1. Cdk4 activity was no longer required in cells lacking functional pRb, while cdk2 activity was required for proliferation in both the presence and absence of pRb function. Using inducible PyLT cell lines, we further demonstrated that pRb inactivation leads to increased cyclin A expression, cdk2 activation and proliferation in antiestrogen arrested cells. These results demonstrate that antiestrogens do not inhibit cdk2 activity or proliferation of MCF-7 cells in the absence of pRb family function, and suggest that antiestrogen resistant breast cancer cells resulting from pRb pathway inactivation would be susceptible to therapies that target cdk2."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001256.g005"/>

  <meta property="og:title" content="Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001256" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=967'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=2221'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=8728&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001256">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001256" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001256&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Hemant Varma
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:hv2108@columbia.edu">hv2108@columbia.edu</a></p>

                <p>Affiliation:
                  Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, United States of America
                </p>

                <p>
                    Current address: Department of Biological Sciences, Columbia University, New York, New York, United States of America
                </p>

              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Andrew J. Skildum, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Susan E. Conrad
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: December 05, 2007</li>
    <li>DOI: 10.1371/journal.pone.0001256</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001256" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001256" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001256" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001256" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001256-g001" data-doi="info:doi/10.1371/journal.pone.0001256" data-uri="info:doi/10.1371/journal.pone.0001256.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001256-g002" data-doi="info:doi/10.1371/journal.pone.0001256" data-uri="info:doi/10.1371/journal.pone.0001256.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001256-g003" data-doi="info:doi/10.1371/journal.pone.0001256" data-uri="info:doi/10.1371/journal.pone.0001256.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001256-g004" data-doi="info:doi/10.1371/journal.pone.0001256" data-uri="info:doi/10.1371/journal.pone.0001256.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001256-g005" data-doi="info:doi/10.1371/journal.pone.0001256" data-uri="info:doi/10.1371/journal.pone.0001256.g005" title="Figure 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001256">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001256" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1"></a><p>Estrogens are required for the proliferation of hormone dependent breast cancer cells, making estrogen receptor (ER) positive tumors amenable to endocrine therapies such as antiestrogens. However, resistance to these agents remains a significant cause of treatment failure. We previously demonstrated that inactivation of the retinoblastoma protein (pRb) family tumor suppressors causes antiestrogen resistance in MCF-7 cells, a widely studied model of estrogen responsive human breast cancers. In this study, we investigate the mechanism by which pRb inactivation leads to antiestrogen resistance. Cdk4 and cdk2 are two key cell cycle regulators that can phosphorylate and inactivate pRb, therefore we tested whether these kinases are required in cells lacking pRb function. pRb family members were inactivated in MCF-7 cells by expressing polyomavirus large tumor antigen (PyLT), and cdk activity was inhibited using the cdk inhibitors p16<sup>INK4A</sup> and p21<sup>Waf1/Cip1</sup>. Cdk4 activity was no longer required in cells lacking functional pRb, while cdk2 activity was required for proliferation in both the presence and absence of pRb function. Using inducible PyLT cell lines, we further demonstrated that pRb inactivation leads to increased cyclin A expression, cdk2 activation and proliferation in antiestrogen arrested cells. These results demonstrate that antiestrogens do not inhibit cdk2 activity or proliferation of MCF-7 cells in the absence of pRb family function, and suggest that antiestrogen resistant breast cancer cells resulting from pRb pathway inactivation would be susceptible to therapies that target cdk2.</p>
</div>


<div class="articleinfo"><p><strong>Citation: </strong>Varma H, Skildum AJ, Conrad SE (2007) Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells. PLoS ONE 2(12):
          e1256.
            doi:10.1371/journal.pone.0001256</p><p><strong>Academic Editor: </strong>Anja-Katrin Bielinsky, University of Minnesota, United States of America</p><p><strong>Received:</strong> August 15, 2007; <strong>Accepted:</strong> November 7, 2007; <strong>Published:</strong> December 5, 2007</p><p><strong>Copyright:</strong> © 2007 Varma et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>NIH Grant CA76647 and Jean P. Schultz Endowed Oncology Fund for Cancer Research, Michigan State University</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Approximately 40 percent of human breast tumors depend on estrogens for proliferation <a href="#pone.0001256-Melora1">[1]</a>, and are therefore treated with drugs such as antiestrogens and aromatase inhibitors, which target the estrogen receptor (ER) <a href="#pone.0001256-Cigler1">[2]</a>. While these therapies are very effective, the development of resistance remains an important problem that leads to relapse in many patients <a href="#pone.0001256-Cigler1">[2]</a>. Multiple mechanisms have been proposed to cause acquired antiestrogen resistance in breast cancer cells, but all of these mechanisms must ultimately converge on the cell cycle machinery since antiestrogens block proliferation of these cells by affecting the cell cycle machinery <a href="#pone.0001256-Brunner1">[3]</a>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Estrogens and antiestrogens control proliferation of breast cancer cells by regulating the expression of multiple components of the cell cycle machinery including cyclins D1 and A, cdc25a and the cyclin dependent kinase inhibitors p21<sup>Waf1/Cip1</sup> (p21), and p27 <sup>Kip1</sup> (p27) <a href="#pone.0001256-Foster1">[4]</a>, <a href="#pone.0001256-Prall1">[5]</a>, <a href="#pone.0001256-Cariou1">[6]</a>. These molecules regulate the activity of the cyclin dependent kinases (cdks), cdk4 and cdk2, which in turn phosphorylate and inactivate tumor suppressors of the retinoblastoma protein (pRb) family <a href="#pone.0001256-Foster1">[4]</a>. The pRb family of proteins inhibit the G1 to S phase transition by sequestering the E2F family of transcription factors <a href="#pone.0001256-Sherr1">[7]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>The MCF-7 cell-line is the most widely studied model of estrogen dependent and antiestrogen sensitive human breast cancers <a href="#pone.0001256-Levenson1">[8]</a>. MCF-7 cells were derived from a human tumor, they are ER positive (ER<sup>+</sup>), and their proliferation is stimulated by estrogens and inhibited by antiestrogens <em>in vivo</em> and <em>in vitro</em> <a href="#pone.0001256-Lippman1">[9]</a>. They contain wild type pRb <a href="#pone.0001256-TAng1">[10]</a>, and estrogen treatment leads to phosphorylation of pRb, cdk activation and progression into S phase <a href="#pone.0001256-Prall1">[5]</a>, <a href="#pone.0001256-PlanasSilva1">[11]</a>. We previously investigated if pRb inactivation is sufficient to cause antiestrogen resistance in MCF-7 cells by expressing large tumor antigens (LT) of SV40 or Polyoma viruses, which bind to and inactivate pRb family proteins. We found that expression of either SV40 LT or Polyoma LT (PyLT) induced proliferation of antiestrogen arrested MCF-7 cells, and that this effect was dependent upon an intact pRb binding domain <a href="#pone.0001256-Varma1">[12]</a>. Furthermore, the ability of SV40 LT to overcome an antiestrogen-induced cell cycle arrest resided within the N-terminal 259 amino acids of the protein, excluding a role for p53 binding and a host of other functions of this large multifunctional protein <a href="#pone.0001256-Varma1">[12]</a>. A recent report using RNAi knockdown of pRb confirmed our results and extended them to <em>in vivo</em> transplants in a murine model <a href="#pone.0001256-Bosco1">[13]</a>. A loss of pRb function occurs in a significant percentage (17 to 26 percent) of breast tumors <a href="#pone.0001256-Dublin1">[14]</a>, <a href="#pone.0001256-Jares1">[15]</a>, <a href="#pone.0001256-Varley1">[16]</a>, and together these results suggest that ER+, pRb negative (pRb<sup>-</sup>) tumors would respond poorly to treatment with antiestrogens.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>In this report, we investigate the mechanism(s) by which pRb inactivation releases breast cancer cells from an antiestrogen-induced cell cycle arrest. Estrogen treatment leads to the activation of both cdk2 and cdk4 in breast cancer cell lines, and both of these kinases can phosphorylate pRb <a href="#pone.0001256-Prall1">[5]</a>, <a href="#pone.0001256-Weinberg1">[17]</a>. We therefore investigated if these kinases are required for proliferation of MCF-7 cells in the absence of functional pRb family members. We demonstrate that cdk4 activity is required for estrogen-induced proliferation in cells with intact pRb function, but not when pRb family members are inactivated. In contrast, cdk2 activity is required irrespective of the pRb status of cells. These results indicate that cdk4 is mainly required for pRb inactivation, while cdk2 has additional targets that are required for MCF-7 cell proliferation. We also demonstrate that expression of PyLT leads to cdk2 activation, even in the presence of antiestrogens. Together, our results support a model in which cdk2 activation in response to estrogen treatment is mediated, at least in part, via pRb inactivation. They also suggest that cdk2, but not cdk4, might be a target for the treatment of ER<sup>+</sup>, pRb<sup>−</sup> tumors that are resistant to antiestrogens or other endocrine treatments.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Results"></a><h3>Results</h3>
<h4>pRb inactivation by PyLT induces proliferation of antiestrogen treated MCF-7 cells</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Our previous results obtained with SV40 LT indicated that the pRb binding domain of LT was required for conferring antiestrogen resistance to MCF-7 cells <a href="#pone.0001256-Varma1">[12]</a>. To confirm that this was also the case for PyLT, plasmids encoding wild type or a pRb binding mutant of LT (Rb-LT) were transiently transfected into MCF-7 cells. The cells were treated with antiestrogen ICI 182,780 (ICI) for 43 h to induce cell cycle arrest, and were then BrdU labeled for an additional 5 h before fixation to assess the percentage of cells that were actively synthesizing DNA. All experiments were conducted in phenol red–free media supplemented with charcoal stripped serum (CSS), which is serum that is depleted of estrogens <a href="#pone.0001256-Darbre1">[18]</a>. The fixed cells were analyzed for PyLT expression and BrdU incorporation by indirect immunofluorescence. Since, in transient transfection experiments only a certain fraction of all cells take up transfected DNA and express detectable levels of PyLT, the percentage of cells that were actively synthesizing DNA was determined in both cells that expressed PyLT (T<sup>+</sup>) and those that did not (T<sup>-</sup>) (<a href="#pone-0001256-g001">Figure 1A</a>, upper panel). The results of this experiment confirmed that PyLT caused antiestrogen resistant proliferation. Furthermore, the pRb binding domain of PyLT was required for this effect, since the Rb-LT mutant was unable to increase proliferation above the levels observed in untransfected cells despite similar expression of the wild type and mutant proteins (<a href="#pone-0001256-g001">Figure 1A</a>, lower panel).</p>
<div class="figure" id="pone-0001256-g001"><div class="img"><a name="pone-0001256-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001256" data-uri="info:doi/10.1371/journal.pone.0001256.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001256.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001256.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>MCF-7 cells expressing PyLT are sensitive to p21 but refractory to p16 arrest.</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p>(A) MCF-7 cells were transfected with wild type PyLT or a Rb binding mutant (Rb-LT) of PyLT, treated with ICI in media supplemented with charcoal stripped serum (CSS), and proliferation was assayed by double indirect immunofluorescence for PyLT and BrdU at 48 h post transfection (<a href="#s4">Materials and Methods</a>). The percentage of BrdU positive cells in PyLT expressing (T<sup>+</sup>) and non-expressing (T<sup>-</sup>) cells is shown. The expression of wild type and mutant PyLT in transfected cells was also assessed by immunoblotting (lower panel, UT = untransfected control). (B) MCF-7 cells were cotransfected with PyLT and either vector (V) alone, or p16/p21 encoding plasmids. Proliferation in the presence of ICI was assayed by double indirect immunofluorescence for PyLT and BrdU. Filled bars (T<sup>+</sup>) represent proliferation in cells expressing PyLT alone or along with vector, p16 or p21. Empty bars (T<sup>-</sup>) represent proliferation in cells that did not express PyLT or PyLT and cotransfected plasmid constructs. (C) The Rb binding mutant (Rb-LT) of PyLT was cotransfected with the above constructs in cycling MCF-7 cells that were treated with E, and proliferation was assayed as described above. All data shown in panels A–C is shown as mean±S.E. of at least three independent experiments, with a minimum of 100 PyLT positive and negative cells counted in each condition.</p>
<span>doi:10.1371/journal.pone.0001256.g001</span></div><a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>We also considered using another estrogen responsive human breast cancer cell line (ZR-75-1) for our experiments, but found this cell line to be much less responsive to 17β-estradiol (E) and ICI compared to the MCF-7 cells (<a href="#pone.0001256.s001">Figure S1</a>). These results are similar to a previous report <a href="#pone.0001256-Chu1">[19]</a>. Since MCF-7 cells are the most widely used experimental model to study the effects of E and ICI on breast cancer proliferation, and results obtained in this cell line are valid in clinical and <em>in vivo</em> models <a href="#pone.0001256-Levenson1">[8]</a>, we decided to use the MCF-7 cells exclusively for further investigation.</p>


<h4>PyLT-induced proliferation is sensitive to the cdk inhibitor p21 but resistant to p16<sup>INK4A</sup></h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>pRb is a physiological target of both cdk4 and cdk2 <a href="#pone.0001256-Weinberg1">[17]</a>. If the primary function of one or both of these kinases in MCF-7 cells is to phosphorylate pRb, then cells in which pRb family members are inactivated by PyLT should no longer require the activity of that kinase for proliferation. To test this possibility, MCF-7 cells were transfected with PyLT alone, or together with vector (V), p16<sup>INK4A</sup> (p16) or p21 expression constructs (see <a href="#s4">Materials and Methods</a> for details about the constructs). p16 is a specific inhibitor of cdk4, while p21 can inhibit both cdk2 and cdk4 but can also facilitate cdk4-cyclin D complex formation <a href="#pone.0001256-Sherr1">[7]</a>, <a href="#pone.0001256-Cheng1">[20]</a>. The ability of these cdk inhibitors to block PyLT-induced proliferation of ICI treated cells was assessed by labeling transfected cells with BrdU as described above, and carrying out double indirect immunofluorescence staining for PyLT and BrdU. In a control experiment, Rb-LT was cotransfected with vector (V), p16 or p21 expression constructs into E treated cells to determine if p16 or p21 inhibited E-induced proliferation of MCF-7 in which pRb was functional. Since in transient co-transfection experiments only a fraction of the cells express the transfected genes, we assessed proliferation both in cells that expressed LT (PyLT or Rb-LT) and the cdk inhibitors (filled bars, T<sup>+</sup>) and those that failed to express the transfected genes (empty bars, T<sup>-</sup>). The results shown in <a href="#pone-0001256-g001">Figures 1B and 1C</a> indicate that cells transfected with the vector alone exhibited a two-fold decrease in proliferation relative to untransfected cells treated with E, or to those transfected with PyLT alone. The reasons for the decreased proliferation in the vector-transfected cells are not clear, however, the decreased proliferation was not down to the levels in ICI-treated cells. The amount of proliferation in vector co-transfected cells therefore served as the baseline to assess the effects of p16 and p21 on PyLT-induced proliferation. As shown in <a href="#pone-0001256-g001">Figure 1B</a>, p21 inhibited PyLT induced proliferation in ICI-treated cells, while p16 did not. However, in control co-transfections with Rb-LT, p16 inhibited E-induced proliferation as efficiently as p21 as seen by decreased BrdU incorporation in transfected cells (T<sup>+</sup>) compared to cells that did not express Rb-LT and p16 (T<sup>-</sup>) (<a href="#pone-0001256-g001">Figure 1C</a>). These results demonstrate that cdk4 activity is required in cells with intact pRb, but not in cells where pRb has been inactivated. In contrast, cdk2 activity is required regardless of the pRb status of cells. They also indicate that cdk4 is required mainly for pRb inactivation, while cdk2 has targets in addition to pRb. Finally, they suggest that antiestrogens do not inhibit cdk2 activity if pRb family members have been inactivated.</p>


<h4>Establishment of cell lines with inducible PyLT expression</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>The results of the transient transfections described above indicated that cdk2 activity is required for PyLT-induced proliferation of ICI treated cells. To test if PyLT induces cdk2 activity, and to address the mechanism of its induction, we established stable inducible cell lines in which expression of PyLT was regulated by the addition of a small molecule dimerizer, AP1510 (AP). The inducible expression system and the selection of stable cell lines are described in more detail in <a href="#s4">Materials and Methods</a>. Briefly, MCF-7 cells were transfected with a vector expressing PyLT from an AP-inducible promoter, transfectants were selected with hygromycin, and resistant clones were expanded into cell lines. The resultant clonal cell lines were screened for PyLT expression by Western blotting (<a href="#pone-0001256-g002">Figure 2A</a>), and several clones with low basal and robust induced levels of PyLT (LT-5 and LT-6) were chosen for further study. Expression of PyLT in the inducible cell lines was also examined by immunofluorescence, and significant variability in PyLT expression was observed in each clonal cell line upon AP treatment, ranging from background to very high levels (<a href="#pone-0001256-g002">Figure 2B</a>). Despite their clonal origin, only 50–60 percent of the cells expressed detectable PyLT even in continued presence of the selective agent. This variability in expression was observed for all the clonal cell lines tested (data not shown).</p>
<div class="figure" id="pone-0001256-g002"><div class="img"><a name="pone-0001256-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001256" data-uri="info:doi/10.1371/journal.pone.0001256.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001256.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001256.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Selection of stable cell lines that express PyLT in an inducible manner.</span></strong></p><a id="article1.body1.sec2.sec3.fig1.caption1.p1" name="article1.body1.sec2.sec3.fig1.caption1.p1"></a><p>(A) Clonal cell lines stably transfected with the inducible PyLT construct were selected as described in <a href="#s4">Materials and Methods</a>, and screened for PyLT expression by immunoblotting after 24 h of AP treatment. Asterisk denotes PyLT clones 5 and 6 that were chosen for further analysis based on robust induction. (B) One clonal cell line (LT-6) was analyzed for PyLT expression by indirect immunofluorescence. Micrographs show PyLT immunofluorescence in the absence and presence of AP for 24 h, and a phase contrast picture of the same field.</p>
<span>doi:10.1371/journal.pone.0001256.g002</span></div>

<h4>PyLT induces cell cycle progression in ICI arrested cells</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>The effects of PyLT expression on cell cycle progression after an ICI-induced G1 arrest were assessed in two independent PyLT inducible clones, LT-5 and LT-6 cells. LT-5 cells were pre-arrested with ICI for 48 h, treated with E, ICI or ICI plus AP, harvested at 12 h intervals, and analyzed by flow cytometry to determine their cell cycle phase distribution. In ICI-treated cultures, expression of PyLT increased the percentage of ICI treated cells in S phase between 12 and 24 h, from 6–7 percent at the 0 h time point to 20 percent by 24 h (<a href="#pone-0001256-g003">Figure 3A</a>, upper panel). As expected, the percentage of cells in G1 decreased and those in G2/M increased after PyLT induction (<a href="#pone-0001256-g003">Figure 3A</a>, lower panel). In comparison, up to 40 percent of cells treated with E were in S phase at the 24 h time point. Similar results were obtained with the LT-6 clone (<a href="#pone.0001256.s002">Figure S2</a>). These experiments demonstrate that though PyLT expression overcomes the cell cycle arrest of ICI treated cells, it is not as effective as E treatment. This was in contrast to the results in the transient transfection experiments where PyLT was as effective as E (<a href="#pone-0001256-g001">Figure 1A and 1C</a>). Since immunofluorescence staining indicated that only 50–60 percent of stably transfected cells expressed detectable levels of PyLT after AP treatment (<a href="#pone-0001256-g002">Figure 2B</a>), we hypothesized that the difference in proliferation between cultures treated with E and ICI+AP might be due to heterogeneous PyLT expression. We therefore analyzed proliferation in high and low PyLT expressing LT-6 cells. Cells were pre-arrested with ICI, then treated with ICI or E in the presence of AP, labeled with BrdU, and fixed at 24 h. Cells were stained for BrdU and PyLT, and the percentage of PyLT positive and PyLT negative cells that were also BrdU positive was determined. BrdU incorporation in cells with high PyLT expression was similar to that in E treated cells (<a href="#pone-0001256-g003">Figure 3B</a>), suggesting that there is a threshold of PyLT expression required to overcome an ICI-induced cell cycle arrest, and that the difference seen between the E and ICI+AP treated samples in <a href="#pone-0001256-g003">Figure 3A</a> is likely the result of sub-threshold PyLT expression in about half the population of cells.</p>
<div class="figure" id="pone-0001256-g003"><div class="img"><a name="pone-0001256-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001256" data-uri="info:doi/10.1371/journal.pone.0001256.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001256.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001256.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>Conditional PyLT expression induces cell cycle progression, an increase in cyclin A and a decrease in p21 in ICI treated cells.</span></strong></p><a id="article1.body1.sec2.sec4.fig1.caption1.p1" name="article1.body1.sec2.sec4.fig1.caption1.p1"></a><p>(A) LT-5 cells were growth arrested in ICI for 48 h, treated with ICI, E or ICI+AP and then harvested at 12 h intervals. The cell cycle profile of each sample was analyzed by flow cytometry, and the percentage of cells in S phase is shown (top panel). The results represent the average±S.D. of one experiment done in triplicate. The percentage of cells in the different phases of the cell cycle is shown in a tabular format (lower panel). The standard deviation was typically less than 2 percent. Similar results were observed for the LT-6 clone (see <a href="#pone.0001256.s002">Figure S2</a>). (B) LT-6 cells were pre-arrested with ICI, treated with ICI+AP or E+AP for 24 h, and BrdU was added to cultures during the final 5 h. Cells were then fixed and stained for both PyLT and BrdU by double indirect immunofluorescence. The percentage of PyLT positive (T<sup>+</sup>) and negative (T<sup>−</sup>) cells that were also BrdU positive is shown. The results represent the average±S.D. of one experiment done in triplicate with a 100 cells counted per condition. (C) LT-5 cells were cultured, treated, and harvested in parallel to those in (A) above. Cell extracts were prepared and analyzed by western blotting for PyLT, cyclins A, E and D1 and the cdk inhibitors p21 and p27. Actin was used as a loading control. Protein levels were quantified by using the Image J software and these values were normalized to actin and are shown below the respective blots. All values are expressed relative to the zero time point that was arbitrarily assigned a value of 1.</p>
<span>doi:10.1371/journal.pone.0001256.g003</span></div>

<h4>PyLT induces cyclin A and decreases p21 expression</h4>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1"></a><p>To examine the effects of PyLT on the expression of proteins that could contribute to antiestrogen resistance, LT-5 cells harvested in parallel to those shown in <a href="#pone-0001256-g003">Figure 3A</a> were analyzed by immunoblotting for PyLT and for cell cycle regulators including cyclins A, E and D1, and the cdk inhibitors p21 and p27 (<a href="#pone-0001256-g003">Figure 3C</a>). A clear induction of PyLT was observed within 6 hours of AP addition, and high levels were maintained for the duration of the experiment. In comparison with the ICI treated cultures, there was no increase in cyclin D1 or cyclin E expression, or a major decrease in p27 expression, in response to AP treatment. However, there was an increase in cyclin A and a decrease in p21 protein levels at the 24 and 36 h time points in the ICI+AP treated cultures. These changes were also present and of greater magnitude in the E-treated cultures, and correlated with the increased percentage of cells in S phase at these time points. Similar changes in cyclin A and p21 protein were confirmed in the LT-6 clone (<a href="#pone.0001256.s002">Figure S2</a>). Both increased cyclin A and decreased p21 expression could contribute to cell cycle progression by increasing cdk2 activity <a href="#pone.0001256-Sherr1">[7]</a>. Decreases in cyclin E and cyclin D1 protein that were observed at later time points in E-treated cells are likely a result of cell cycle progression since these cyclins are known to be degraded in late S phase <a href="#pone.0001256-Sherr2">[21]</a>, <a href="#pone.0001256-Dulic1">[22]</a> and this correlates with an increase in the percentage of cells in S and G2/M (<a href="#pone-0001256-g003">Figure 3A</a>, lower panel). A decrease in cyclin D1 was observed in ICI treated cells and is likely due to the reported down regulation of cyclin D1 by ICI in MCF-7 cells <a href="#pone.0001256-Prall1">[5]</a>, <a href="#pone.0001256-PlanasSilva1">[11]</a>.</p>


<h4>PyLT induces cdk2 activity in ICI treated MCF-7 cells</h4>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1"></a><p>To further examine the mechanism(s) by which PyLT induces proliferation in ICI treated cells we carried out an extended time course experiment. LT-6 cells were pre-arrested with ICI and then treated with media containing estrogen-depleted serum (CSS), ICI or E individually, or in combination with AP. Cells were harvested at 24 h intervals for 4 to 5 days, and analyzed for cell cycle distribution and protein expression. PyLT expression caused an increase in the percentage of cells in S phase to a similar extent in both the absence of E (CSS) and presence of ICI (<a href="#pone-0001256-g004">Figure 4A</a>). The percentage of LT-6 cells in S phase was high in E treated cells and was not substantially increased upon PyLT induction by AP treatment. This indicates that PyLT is not able to further increase proliferation in E treated cells, and that neither AP treatment nor PyLT expression interferes with E stimulated proliferation. In all treatments, two rounds of DNA synthesis can be clearly seen, indicating that PyLT is able to promote antiestrogen resistant proliferation for at least two cell cycles. We noted that progression into the second cell cycle took longer than the first cell cycle. There are two potential contributors to this delay. First, antiestrogen treatment of MCF-7 cells causes a cell cycle arrest in the early to mid G1 <a href="#pone.0001256-Osborne1">[23]</a>. Thus, cells released from an antiestrogen block (by E or PyLT) would traverse from this point in G1 phase to S phase. However to enter the S phase of second cell cycle, cells would take additional time to traverse the G2/M phase of the first cell cycle, and the complete G1 of the second cell cycle. A second contributor could be that antiestrogen arrested cells are synchronized in G1 and they progress synchronously from G1 to S phase upon release (by E or PyLT), but by the second cell cycle they enter S phase in a less synchronized manner. This could account for the prolonged but substantially lower S phase peak of the second cell cycle and is consistent with the cells entering the S phase over a prolonged period of time.</p>
<div class="figure" id="pone-0001256-g004"><div class="img"><a name="pone-0001256-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001256" data-uri="info:doi/10.1371/journal.pone.0001256.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001256.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001256.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>PyLT induces proliferation of ICI treated cells over 2 cell cycles and activates cdk2.</span></strong></p><a id="article1.body1.sec2.sec6.fig1.caption1.p1" name="article1.body1.sec2.sec6.fig1.caption1.p1"></a><p>(A) LT-6 cells were growth arrested in ICI for 48 h, then treated with CSS, CSS+ICI, CSS+AP, CSS+E, CSS+AP+E or CSS+ICI+AP. Cells were then harvested at 24 h intervals and the cell cycle profile was analyzed by flow cytometry. The percentages of cells in S phase at various time points are shown. The results are from one experiment, with at least 10,000 cells analyzed per sample. (B) LT-6 cells were arrested with ICI and treated with ICI+AP as described in (A). Cell extracts were prepared at the indicated time points, and analyzed for PyLT and cyclin A expression by immunoblotting. A time-matched control of cells treated with ICI alone (ICI 24 h) was included. Actin was used as a loading control. (C) LT-6 cells were growth arrested with ICI as described in (A), then PyLT was induced by ICI+AP treatment. Time matched controls (24 h) of cells incubated in ICI or E were included as negative and positive controls, respectively. Cell extracts were prepared at 24 h intervals and analyzed for cdk2 <em>in vitro</em> kinase activity using histone H1 (HH1) as a substrate. Control IgG (E 24, IgG) was used as a control for antibody specificity. The level of cdk2 activity was quantified by phosphorimager scanning and is shown below the autoradiograph. The values are relative to the E 24 h time point that was set as 100%. (D) The cdk2 activity was determined after 24 h treatment of LT-6 cells with ICI, ICI+AP or E and is expressed relative to the activity in E treated samples that was set as a 100%. The results are the average±S.D. of two independent experiments.</p>
<span>doi:10.1371/journal.pone.0001256.g004</span></div><a id="article1.body1.sec2.sec6.p2" name="article1.body1.sec2.sec6.p2"></a><p>Next we directly tested the effects of PyLT expression on cdk2 activity. In a parallel experiment to that described above, ICI arrested cells were induced with AP, harvested at 24 h intervals for 4 days and subjected to western blotting and <em>in vitro</em> kinase assays for cdk2 activity. ICI and E treated cells were harvested at 24 h, and served as negative and positive controls, respectively. As shown in <a href="#pone-0001256-g004">Figure 4B</a>, cyclin A levels peaked at 24 and 96 h, the time points with the highest percentage of cells in S phase. Cdk2 activity was highly induced at 24 h in the ICI+AP treated cells compared to either the 0 h or the 24 h ICI treated time points (<a href="#pone-0001256-g004">Figure 4C</a>). However, E treated cells had approximately two-fold higher cdk2 activity (<a href="#pone-0001256-g004">Figures 4C and 4D</a>) at the 24 h time point than the ICI+AP treated cells, which correlated with the increased percentage of cells in S phase in these cultures (<a href="#pone-0001256-g004">Figures 4A</a>). Thus, PyLT expression caused an increase in cdk2 activity that closely paralleled cyclin A protein levels and S phase entry in ICI+AP treated MCF-7 cells.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>We have demonstrated that expression of viral tumor antigens (SV40 LT and PyLT) causes antiestrogen resistance in MCF-7 cells, and that the pRb binding and inactivation domain of these proteins is required for this effect (<a href="#pone-0001256-g001">Figure 1A</a>) <a href="#pone.0001256-Varma1">[12]</a>. The viral LT antigens are multifunctional proteins <a href="#pone.0001256-Brodsky1">[24]</a>, and our results cannot exclude the possibility that other functional domains contribute to antiestrogen resistant proliferation. However, LT mutants that are defective in p53 binding and truncation mutants (N terminal 1–259 and 1–136 amino acids) that lack most functional domains except the pRb inactivation domain, caused similar levels of antiestrogen resistance as full length SV40 LT or PyLT (<a href="#pone.0001256-Varma1">[12]</a> and data not shown). In addition, pRb knockdown using RNA interference causes antiestrogen resistance in breast cancer cells <em>in vitro</em> and in <em>vivo</em> <a href="#pone.0001256-Bosco1">[13]</a>, <a href="#pone.0001256-Bosco2">[25]</a>. Together these results indicate that pRb inactivation is sufficient to cause antiestrogen resistance.</p>
<a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>We have used the PyLT model to investigate the mechanisms by which pRb inactivation alleviates an antiestrogen-induced cell cycle arrest in MCF-7 cells. Both cdk4 and cdk2 activities are regulated by estrogen and antiestrogens in these cells <a href="#pone.0001256-Prall1">[5]</a>, <a href="#pone.0001256-PlanasSilva1">[11]</a>, and both can phosphorylate pRb <a href="#pone.0001256-Weinberg1">[17]</a> . We therefore asked whether the activity of both these kinases is required in the presence and absence of functional pRb. Using the cdk inhibitors p16 (cdk4) and p21 (cdk4 and cdk2), we confirmed that both cdk4 and cdk2 are required for 17ß-estradiol's proliferative effects in MCF-7 cells with functional pRb (<a href="#pone-0001256-g001">Figure 1C</a>). However, in cells where PyLT abrogated the pRb function, inhibition of cdk2 blocked proliferation while inhibition of cdk4 had no effect (<a href="#pone-0001256-g001">Figure 1B</a>). These results are consistent with a model in which the only requirement of cdk4 in MCF-7 cell proliferation is to inactivate pRb family members <a href="#pone.0001256-Lukas1">[26]</a>, <a href="#pone.0001256-Mann1">[27]</a>. Although additional tissue specific roles for cdk4 have been suggested <a href="#pone.0001256-Camarda1">[28]</a>, they do not appear to be required in this breast cancer cell culture model. The results that cdk2 activity is induced upon PyLT expression in ICI treated cells and cdk2 activity is required even in the absence of functional pRb (<a href="#pone-0001256-g004">Figure 4C</a>), support a model in which cdk2 is downstream of pRb and has additional targets <a href="#pone.0001256-Mann1">[27]</a>, <a href="#pone.0001256-SantoniRugiu1">[29]</a>. However, it is important to note that cdk2 is not essential for all cell cycle progression, since genetic knockout of cdk2 does not prevent somatic cell proliferation in mice <a href="#pone.0001256-Sherr3">[30]</a>. Furthermore, a requirement for cdk2 activity in viral tumor antigen-induced proliferation is not universal, since both adenoviral E1A and SV40 LT were reported to overcome a cdk2 inhibitor (p27)-induced cell cycle arrest without increasing cdk2 activity <a href="#pone.0001256-Alevizopoulos1">[31]</a>, <a href="#pone.0001256-Zhang1">[32]</a>. Although we have not tested p27's ability to inhibit proliferation in our study, others have reported that p27 inhibits proliferation of MCF-7 cells <a href="#pone.0001256-Foster1">[4]</a>, <a href="#pone.0001256-Cariou1">[6]</a>. The differences observed between the various systems studied could be due to differences in oncoproteins, cdk2 inhibitors, cell type, or anti-proliferative signals (serum starvation versus antiestrogen treatment) employed.</p>
<a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3"></a><p>An important issue raised by our results is whether pRb inactivation is sufficient to confer complete antiestrogen resistance. In our inducible cell lines, expression of PyLT caused cell cycle progression in ICI treated cells, but the maximum percentage of cells in S phase was approximately two fold lower than in E treated cells (<a href="#pone-0001256-g003">Figure 3A</a> and <a href="#pone.0001256.s002">Figure S2</a>). Similarly, cdk2 activity was highly induced after PyLT induction, but only to approximately 50 percent of that seen in E treated cells (<a href="#pone-0001256-g004">Figure 4D</a>). A likely explanation for at least part of the difference between ICI+AP and E treated cells is heterogeneous PyLT expression, since only 50–60 percent cells in the inducible cell lines expressed detectable PyLT upon AP induction (<a href="#pone-0001256-g002">Figure 2B</a>). When only cells expressing detectable PyLT in the presence of ICI were scored for BrdU incorporation, the percentage of positive cells was similar to that seen in E treatments (<a href="#pone-0001256-g003">Figure 3B</a>). However, E has multiple targets in MCF-7 cells, including c-myc, p21, and cdc25A <a href="#pone.0001256-Foster1">[4]</a>, <a href="#pone.0001256-Mukherjee1">[33]</a>, <a href="#pone.0001256-Prall2">[34]</a>, <a href="#pone.0001256-Skildum1">[35]</a>. Some of these targets may act independently of pRb <a href="#pone.0001256-SantoniRugiu1">[29]</a>, and disruption of their regulation may be important for maximal cdk2 activation and proliferation in the presence of antiestrogens.</p>
<a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4"></a><p>A final question is the mechanism by which pRb inactivation leads to cdk activation and cell cycle progression in MCF-7 cells. Cdk2 can associate with both cyclin E and cyclin A, and the activity of both cyclin E/cdk2 and cyclin A/cdk2 complexes increased after PyLT induction in ICI treated cells (data not shown). Since the cyclin A promoter is regulated in an E2F dependent manner <a href="#pone.0001256-Schulze1">[36]</a>, the release of E2F upon pRb inactivation likely explains the increases in cyclin A expression (<a href="#pone-0001256-g003">Figure 3C</a>) and cyclin A/cdk2 activity upon PyLT induction. The mechanism of cyclin E/cdk2 activation is less clear, since cyclin E levels do not increase after PyLT expression (<a href="#pone-0001256-g003">Figure 3C</a>). A small but reproducible decrease in p21 expression was observed, which could increase the number of active cyclin E/cdk2 complexes. In addition, the formation of new cyclin A/cdk2 complexes could titrate both p21 and p27 away from cyclin E/cdk2 complexes, thereby leading to their activation <a href="#pone.0001256-PlanasSilva1">[11]</a>.</p>
<a id="article1.body1.sec3.p5" name="article1.body1.sec3.p5"></a><p>In summary, these results support a model in which the mitogenic effects of estrogen in breast cancer cells are largely mediated by inactivation of pRb and/or related family members, which in turn leads to cdk2 activation and cell cycle progression (<a href="#pone-0001256-g005">Figure 5</a>). Our result that antiestrogens do not effectively inhibit cdk2 activity or proliferation in the absence of pRb function suggests that inhibition of cdk2 activity is critical to the antiproliferative effects of antiestrogens, and this is supported by the fact that loss of either p21 or p27 causes antiestrogen resistance <a href="#pone.0001256-Cariou1">[6]</a>. The Rb tumor suppressor gene is mutated in approximately 25 percent of breast cancers, and a larger percentage show alterations in the pRb pathway resulting from overexpression of cyclin D1 or loss of p16 <a href="#pone.0001256-Dublin1">[14]</a>, <a href="#pone.0001256-Jares1">[15]</a>. Many of these pRb<sup>−</sup> tumors would likely express ER, and would therefore be treated with compounds that target ER. Our results suggest that such pRb<sup>−</sup>, ER<sup>+</sup> tumors would be resistant to such treatments, but would retain sensitivity to pharmacological inhibitors of cdk2. These inhibitors of cdk2 that are in clinical trials <a href="#pone.0001256-Fischer1">[37]</a> are potential therapies for antiestrogen resistant breast cancers with alterations in the pRb pathway.</p>
<div class="figure" id="pone-0001256-g005"><div class="img"><a name="pone-0001256-g005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001256" data-uri="info:doi/10.1371/journal.pone.0001256.g005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001256.g005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001256.g005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001256.g005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001256.g005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001256.g005.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 5.  <span>Model of E mediated proliferation of MCF-7 cells.</span></strong></p><span>doi:10.1371/journal.pone.0001256.g005</span></div></div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Cell culture</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p>MCF-7 cells were obtained from the Dr. M. Johnson at the Lombardi Cancer Center and ZR-75-1 cells were from the American Type Culture Collection (Manassas, VA). These cells were routinely maintained in IMEM (Biofluids) containing 5% fetal bovine serum (FBS) (HyClone), penicillin (100 units/ml) and streptomycin (100 µg/ml). Charcoal Stripped Serum (HyClone) containing media was used for some experiments. Media for PyLT inducible clones also contained hygromycin (10 µg/ml) plus G418 (50 µg/ml).</p>


<h4>Cell cycle analysis</h4>
<a id="article1.body1.sec4.sec2.p1" name="article1.body1.sec4.sec2.p1"></a><p>Cells were fixed, stained with propidium iodide, and analyzed with a FACSVantage flow cytometer as previously described <a href="#pone.0001256-Mukherjee1">[33]</a>.</p>


<h4>Plasmids and cloning</h4>
<a id="article1.body1.sec4.sec3.p1" name="article1.body1.sec4.sec3.p1"></a><p>Plasmids encoding the wild type polyoma large T antigen (PyLT) and pRb binding mutant (Rb-LT) were obtained from Dr. Brian Schaffhausen (Tufts University, MA) <a href="#pone.0001256-Howes1">[38]</a>. A control plasmid encoding green fluorescent protein (GFP) from a CMV promoter (Vector) and the same vector encoding p16 and p21 as GFP fusion proteins were obtained from Dr. Steve Weintraub (Washington University, MO). For inducible expression, PyLT cDNA was cloned into the pLH-Z12-I vector <a href="#pone.0001256-Mukherjee1">[33]</a> in a two-step ligation. The PyLT cDNA was excised from the pCMV PyLT vector using <em>Sal</em>I and <em>Bam</em>HI and ligated into <em>Sal</em>I and <em>Bam</em>HI digested pIC19H vector to generate pIC19H-PyLT. In the second step, the PyLT cDNA was excised from pIC19H-PyLT using <em>Sal</em>I (site was filled in with nucleotides using T4 DNA polymerase to generate blunt ends) and <em>Cla</em>I, and ligated into the polylinker region of pLH-Z12-I that was digested with <em>EcoR</em>I (site filled in with nucleotides using T4 DNA polymerase to generate blunt ends) and <em>Cla</em>I, to generate pLH-Z12-PyLT, which was used for establishing stable cell lines.</p>


<h4>Construction of stably transfected cell lines expressing PyLT from an inducible promoter</h4>
<a id="article1.body1.sec4.sec4.p1" name="article1.body1.sec4.sec4.p1"></a><p>A gene regulation system based on small molecule (AP1510)-regulated protein dimerization has been previously described <a href="#pone.0001256-Mukherjee1">[33]</a> (<a href="http://www.ARIAD.com/regulationkits">www.ARIAD.com/regulationkits</a>). The resultant clonal cell lines were expanded and screened for inducible PyLT expression using immunoblotting and indirect immunofluorescence.</p>


<h4>Chemicals and Antibodies</h4>
<a id="article1.body1.sec4.sec5.p1" name="article1.body1.sec4.sec5.p1"></a><p>Chemicals used were: ICI 182,780 (A. Wakeling, Zeneca Pharmaceuticals); 17β-estradiol (E) (Sigma); 5-Bromo-2′-deoxyuridine (BrdU) (Boehringer Mannheim); and AP1510 (ARIAD Pharmaceuticals, Cambridge, MA). The rat polyclonal antibody to PyLT that was used for immunoblotting was a gift of Dr. Michele Fluck (Michigan State University, MI) and the rabbit polyclonal antibody to cdk2 was a gift of Dr. Charles J. Sherr (St. Jude Children's Research Hospital, TN). Additional antibodies used were: Anti-PyLT (Ab-1) rat monoclonal (Oncogene Science), a mouse α-BrdU antibody (Boehringer Mannheim) and FITC conjugated goat anti-rat (Sigma chemicals). Antibodies to p21, p27, actin and cyclins A, D and E, have been described previously <a href="#pone.0001256-Varma2">[39]</a>.</p>


<h4>Immunoblotting</h4>
<a id="article1.body1.sec4.sec6.p1" name="article1.body1.sec4.sec6.p1"></a><p>Immunoblotting was performed as described previously <a href="#pone.0001256-Varma2">[39]</a>. Western blots were quantified using the Image J software (National Institute of Health, Bethesda, MD).</p>


<h4>Indirect Immunofluorescence</h4>
<a id="article1.body1.sec4.sec7.p1" name="article1.body1.sec4.sec7.p1"></a><p>MCF-7 cells were transfected with either the PyLT plasmid alone (0.3 µg) or in combination with 1 µg of pGFP (Vector), p16 or p21 as described previously <a href="#pone.0001256-Varma1">[12]</a> . After transfection, cells were treated with medium containing 5% charcoal stripped serum (CSS) and ICI (100 nM) and were labeled with 25 µM BrdU for 5 h before fixation at 48 h post transfection. The double immunofluorescence procedure for detecting transfected proteins and BrdU was described previously <a href="#pone.0001256-Varma1">[12]</a>. BrdU incorporation was detected using a mouse α-BrdU antibody <a href="#pone.0001256-Varma1">[12]</a>. PyLT was detected using the rat monoclonal anti-PyLT (Ab-1) antibody (10 µg/ml in PBS) followed by an FITC labeled goat anti-rat antibody (1:150 dilution in 1% BSA in PBS). The percentage of PyLT expressing and non-expressing cells that were positive for BrdU was determined, with a minimum of 100 cells being counted in each condition per experiment. For the detection of PyLT expression in PyLT stable inducible cell lines, cells were treated with AP (300 nM) or vehicle and fixed 24 h after treatment. Immunofluorescence for PyLT was performed as described above. For BrdU incorporation in stable cell lines, cells were incubated in CSS+ICI (100 nM) containing media for 2 days, and then transferred to CSS+E (10 nM)+AP (300 nM) or CSS+ICI (100 nM)+AP (300 nM) containing media. After 19 h the cells were labeled with BrdU (25 µM) for 5 h, then fixed and analyzed by double indirect immunofluorescence as described above.</p>


<h4>Immunoprecipitations and kinase assays</h4>
<a id="article1.body1.sec4.sec8.p1" name="article1.body1.sec4.sec8.p1"></a><p>Immunoprecipitations (IP) and cdk2 activity assays were performed using a modification of a published method <a href="#pone.0001256-Matsushime1">[40]</a> as described previously <a href="#pone.0001256-Skildum1">[35]</a>. For IP experiments, 75 µg of total cellular protein lysate was incubated with specific (anti-cdk2) or control (normal goat IgG) antibodies. Kinase activity in the resulting precipitates was measured using 2 µg Histone H1 (HH1) substrate. Phosphorylated HH1 bands were quantified by phosphorimager (Molecular Dynamics).</p>

</div>

<div id="section5" class="section"><a id="s5" name="s5" toc="s5" title="Supporting Information"></a><h3>Supporting Information</h3><div class="figshare_widget" doi="10.1371/journal.pone.0001256"></div><a name="pone.0001256.s001" id="pone.0001256.s001"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0001256.s001">Figure S1. </a></strong></p><a id="article1.body1.sec5.supplementary-material1.caption1.p1" name="article1.body1.sec5.supplementary-material1.caption1.p1"></a><p class="preSiDOI">Relative estrogen and antiestrogen sensitivity of two ER+ human breast cancer cell lines. MCF-7 and ZR-75-1 cells were plated in regular growth medium for 24 h and then shifted to media containing ICI (100 nM) or E (10 nM). Cells were harvested after 48 h and cell cycle analysis was performed as described in <a href="#s4">Materials and Methods</a>. The percentage of cells in S phase is shown from one experiment performed in triplicate. Error bars represent 1 S.D.</p>
<p class="siDoi">doi:10.1371/journal.pone.0001256.s001</p><a id="article1.body1.sec5.supplementary-material1.caption1.p2" name="article1.body1.sec5.supplementary-material1.caption1.p2"></a><p class="postSiDOI">(0.65 MB EPS)</p>
<a name="pone.0001256.s002" id="pone.0001256.s002"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0001256.s002">Figure S2. </a></strong></p><a id="article1.body1.sec5.supplementary-material2.caption1.p1" name="article1.body1.sec5.supplementary-material2.caption1.p1"></a><p class="preSiDOI">Conditional PyLT expression induces cell cycle progression and an increase in cyclin A in the LT-6 clone. (A) LT-6 cells were growth arrested in ICI for 48 h, treated with CSS+ICI, CSS+E or CSS+ICI+AP and then harvested at 12 h intervals. The cell cycle profile of each sample was analyzed by flow cytometry, and the percentage of cells in S phase is shown. The results represent the average±S.D. of a single experiment done in triplicate. (B) In parallel, cells were harvested for immunoblotting and the levels of PyLT, cyclin A, p21 and actin were determined. The western blots were quantified and normalized to actin levels using Image J software. The zero h time point was arbitrarily set as 1.</p>
<p class="siDoi">doi:10.1371/journal.pone.0001256.s002</p><a id="article1.body1.sec5.supplementary-material2.caption1.p2" name="article1.body1.sec5.supplementary-material2.caption1.p2"></a><p class="postSiDOI">(1.23 MB EPS)</p>
</div>



<div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: HV SC AS. Performed the experiments: HV AS. Analyzed the data: HV SC AS. Wrote the paper: HV SC.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001256-Melora1" id="pone.0001256-Melora1"></a>Melora DB, Allred CC, O'Conell P (1998)  Principles of Molecular Medicine;. In: Jameson JL, editor. Humana Press. pp. 625–632.  <ul class="find-nolinks"></ul></li><li><span class="label">2.
              </span><a name="pone.0001256-Cigler1" id="pone.0001256-Cigler1"></a>Cigler T, Goss PE (2007) Breast cancer adjuvant endocrine therapy. Cancer journal (Sudbury, Mass)  13: 148–155.  <ul class="find" data-citedArticleID="1025274" data-doi="10.1097/ppo.0b013e318074d363"><li><a href="http://dx.doi.org/10.1097/ppo.0b013e318074d363" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Breast+cancer+adjuvant+endocrine+therapy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Breast+cancer+adjuvant+endocrine+therapy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001256-Brunner1" id="pone.0001256-Brunner1"></a>Brèunner N, Bronzert D, Vindel2v LL, Rygaard K, Spang-Thomsen M, et al.  (1989) Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer research  49: 1515–1520.  <ul class="find" data-citedArticleID="1025264"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Effect+on+growth+and+cell+cycle+kinetics+of+estradiol+and+tamoxifen+on+MCF-7+human+breast+cancer+cells+grown+in+vitro+and+in+nude+mice.&amp;auth=&amp;atitle=Effect+on+growth+and+cell+cycle+kinetics+of+estradiol+and+tamoxifen+on+MCF-7+human+breast+cancer+cells+grown+in+vitro+and+in+nude+mice." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Effect+on+growth+and+cell+cycle+kinetics+of+estradiol+and+tamoxifen+on+MCF-7+human+breast+cancer+cells+grown+in+vitro+and+in+nude+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Effect+on+growth+and+cell+cycle+kinetics+of+estradiol+and+tamoxifen+on+MCF-7+human+breast+cancer+cells+grown+in+vitro+and+in+nude+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001256-Foster1" id="pone.0001256-Foster1"></a>Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J (2001) Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol Cell Biol  21: 794–810.  <ul class="find" data-citedArticleID="1025284" data-doi="10.1128/mcb.21.3.794-810.2001"><li><a href="http://dx.doi.org/10.1128/mcb.21.3.794-810.2001" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Multifaceted+regulation+of+cell+cycle+progression+by+estrogen%3A+regulation+of+Cdk+inhibitors+and+Cdc25A+independent+of+cyclin+D1-Cdk4+function." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Multifaceted+regulation+of+cell+cycle+progression+by+estrogen%3A+regulation+of+Cdk+inhibitors+and+Cdc25A+independent+of+cyclin+D1-Cdk4+function.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001256-Prall1" id="pone.0001256-Prall1"></a>Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL (1997) Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E- Cdk2. J Biol Chem  272: 10882–10894.  <ul class="find" data-citedArticleID="1025308" data-doi="10.1074/jbc.272.16.10882"><li><a href="http://dx.doi.org/10.1074/jbc.272.16.10882" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Estrogen-induced+activation+of+Cdk4+and+Cdk2+during+G1-S+phase+progression+is+accompanied+by+increased+cyclin+D1+expression+and+decreased+cyclin-dependent+kinase+inhibitor+association+with+cyclin+E-+Cdk2." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Estrogen-induced+activation+of+Cdk4+and+Cdk2+during+G1-S+phase+progression+is+accompanied+by+increased+cyclin+D1+expression+and+decreased+cyclin-dependent+kinase+inhibitor+association+with+cyclin+E-+Cdk2.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001256-Cariou1" id="pone.0001256-Cariou1"></a>Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, et al.  (2000) Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen- mediated cell cycle arrest in human breast cancer cells. Proc Natl Acad Sci U S A  97: 9042–9046.  <ul class="find" data-citedArticleID="1025268" data-doi="10.1073/pnas.160016897"><li><a href="http://dx.doi.org/10.1073/pnas.160016897" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Down-regulation+of+p21WAF1%2FCIP1+or+p27Kip1+abrogates+antiestrogen-+mediated+cell+cycle+arrest+in+human+breast+cancer+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Down-regulation+of+p21WAF1%2FCIP1+or+p27Kip1+abrogates+antiestrogen-+mediated+cell+cycle+arrest+in+human+breast+cancer+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001256-Sherr1" id="pone.0001256-Sherr1"></a>Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev  13: 1501–1512.  <ul class="find" data-citedArticleID="1025316" data-doi="10.1101/gad.13.12.1501"><li><a href="http://dx.doi.org/10.1101/gad.13.12.1501" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=CDK+inhibitors%3A+positive+and+negative+regulators+of+G1-phase+progression." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22CDK+inhibitors%3A+positive+and+negative+regulators+of+G1-phase+progression.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001256-Levenson1" id="pone.0001256-Levenson1"></a>Levenson AS, Jordan VC (1997) MCF-7: the first hormone-responsive breast cancer cell line. Cancer research  57: 3071–3078.  <ul class="find" data-citedArticleID="1025290"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=MCF-7%3A+the+first+hormone-responsive+breast+cancer+cell+line.&amp;auth=&amp;atitle=MCF-7%3A+the+first+hormone-responsive+breast+cancer+cell+line." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=MCF-7%3A+the+first+hormone-responsive+breast+cancer+cell+line." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22MCF-7%3A+the+first+hormone-responsive+breast+cancer+cell+line.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001256-Lippman1" id="pone.0001256-Lippman1"></a>Lippman M, Bolan G, Huff K (1976) The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res  36: 4595–4601.  <ul class="find" data-citedArticleID="1025292" data-doi="10.1038/258339a0"><li><a href="http://dx.doi.org/10.1038/258339a0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+effects+of+estrogens+and+antiestrogens+on+hormone-responsive+human+breast+cancer+in+long-term+tissue+culture." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+effects+of+estrogens+and+antiestrogens+on+hormone-responsive+human+breast+cancer+in+long-term+tissue+culture.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001256-TAng1" id="pone.0001256-TAng1"></a>T'Ang A, Varley JM, Chakraborty S, Murphree AL, Fung YK (1988) Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science  242: 263–266.  <ul class="find" data-citedArticleID="1025324" data-doi="10.1126/science.3175651"><li><a href="http://dx.doi.org/10.1126/science.3175651" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Structural+rearrangement+of+the+retinoblastoma+gene+in+human+breast+carcinoma." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Structural+rearrangement+of+the+retinoblastoma+gene+in+human+breast+carcinoma.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001256-PlanasSilva1" id="pone.0001256-PlanasSilva1"></a>Planas-Silva MD, Weinberg RA (1997) Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol Cell Biol  17: 4059–4069.  <ul class="find" data-citedArticleID="1025306"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Estrogen-dependent+cyclin+E-cdk2+activation+through+p21+redistribution.&amp;auth=&amp;atitle=Estrogen-dependent+cyclin+E-cdk2+activation+through+p21+redistribution." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Estrogen-dependent+cyclin+E-cdk2+activation+through+p21+redistribution." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Estrogen-dependent+cyclin+E-cdk2+activation+through+p21+redistribution.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001256-Varma1" id="pone.0001256-Varma1"></a>Varma H, Conrad SE (2000) Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain. Oncogene  19: 4746–4753.  <ul class="find" data-citedArticleID="1025328" data-doi="10.1038/sj.onc.1203827"><li><a href="http://dx.doi.org/10.1038/sj.onc.1203827" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Reversal+of+an+antiestrogen-mediated+cell+cycle+arrest+of+MCF-7+cells+by+viral+tumor+antigens+requires+the+retinoblastoma+protein-binding+domain." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Reversal+of+an+antiestrogen-mediated+cell+cycle+arrest+of+MCF-7+cells+by+viral+tumor+antigens+requires+the+retinoblastoma+protein-binding+domain.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001256-Bosco1" id="pone.0001256-Bosco1"></a>Bosco EE, Wang Y, Xu H, Zilfou JT, Knudsen KE, et al.  (2007) The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. J Clin Invest  117: 218–228.  <ul class="find" data-citedArticleID="1025258" data-doi="10.1172/jci28803"><li><a href="http://dx.doi.org/10.1172/jci28803" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+retinoblastoma+tumor+suppressor+modifies+the+therapeutic+response+of+breast+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+retinoblastoma+tumor+suppressor+modifies+the+therapeutic+response+of+breast+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001256-Dublin1" id="pone.0001256-Dublin1"></a>Dublin EA, Patel NK, Gillett CE, Smith P, Peters G, et al.  (1998) Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters. Int J Cancer  79: 71–75.  <ul class="find" data-citedArticleID="1025278" data-doi="10.1002/(sici)1097-0215(19980220)79:1<71::aid-ijc14&gt;3.0.co;2-k"><li><a href="http://dx.doi.org/10.1002/(sici)1097-0215(19980220)79:1<71::aid-ijc14&gt;3.0.co;2-k" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Retinoblastoma+and+p16+proteins+in+mammary+carcinoma%3A+their+relationship+to+cyclin+D1+and+histopathological+parameters." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Retinoblastoma+and+p16+proteins+in+mammary+carcinoma%3A+their+relationship+to+cyclin+D1+and+histopathological+parameters.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001256-Jares1" id="pone.0001256-Jares1"></a>Jares P, Rey MJ, Fernandez PL, Campo E, Nadal A, et al.  (1997) Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status. J Pathol  182: 160–166.  <ul class="find" data-citedArticleID="1025288" data-doi="10.1002/(sici)1096-9896(199706)182:2<160::aid-path814&gt;3.3.co;2-u"><li><a href="http://dx.doi.org/10.1002/(sici)1096-9896(199706)182:2<160::aid-path814&gt;3.3.co;2-u" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cyclin+D1+and+retinoblastoma+gene+expression+in+human+breast+carcinoma%3A+correlation+with+tumour+proliferation+and+oestrogen+receptor+status." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cyclin+D1+and+retinoblastoma+gene+expression+in+human+breast+carcinoma%3A+correlation+with+tumour+proliferation+and+oestrogen+receptor+status.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001256-Varley1" id="pone.0001256-Varley1"></a>Varley JM, Armour J, Swallow JE, Jeffreys AJ, Ponder BA, et al.  (1989) The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene  4: 725–729.  <ul class="find" data-citedArticleID="1025326"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+retinoblastoma+gene+is+frequently+altered+leading+to+loss+of+expression+in+primary+breast+tumours.&amp;auth=&amp;atitle=The+retinoblastoma+gene+is+frequently+altered+leading+to+loss+of+expression+in+primary+breast+tumours." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+retinoblastoma+gene+is+frequently+altered+leading+to+loss+of+expression+in+primary+breast+tumours." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+retinoblastoma+gene+is+frequently+altered+leading+to+loss+of+expression+in+primary+breast+tumours.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001256-Weinberg1" id="pone.0001256-Weinberg1"></a>Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell  81: 323–330.  <ul class="find" data-citedArticleID="1025332" data-doi="10.1016/0092-8674(95)90385-2"><li><a href="http://dx.doi.org/10.1016/0092-8674(95)90385-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+retinoblastoma+protein+and+cell+cycle+control." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+retinoblastoma+protein+and+cell+cycle+control.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001256-Darbre1" id="pone.0001256-Darbre1"></a>Darbre P, Yates J, Curtis S, King RJ (1983) Effect of estradiol on human breast cancer cells in culture. Cancer Res  43: 349–354.  <ul class="find" data-citedArticleID="1025276"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Effect+of+estradiol+on+human+breast+cancer+cells+in+culture.&amp;auth=&amp;atitle=Effect+of+estradiol+on+human+breast+cancer+cells+in+culture." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Effect+of+estradiol+on+human+breast+cancer+cells+in+culture." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Effect+of+estradiol+on+human+breast+cancer+cells+in+culture.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001256-Chu1" id="pone.0001256-Chu1"></a>Chu I, Blackwell K, Chen S, Slingerland J (2005) The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer. Cancer research  65: 18–25.  <ul class="find" data-citedArticleID="1025272"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=The+dual+ErbB1%2FErbB2+inhibitor%2C+lapatinib+%28GW572016%29%2C+cooperates+with+tamoxifen+to+inhibit+both+cell+proliferation-+and+estrogen-dependent+gene+expression+in+antiestrogen-resistant+breast+cancer.&amp;auth=&amp;atitle=The+dual+ErbB1%2FErbB2+inhibitor%2C+lapatinib+%28GW572016%29%2C+cooperates+with+tamoxifen+to+inhibit+both+cell+proliferation-+and+estrogen-dependent+gene+expression+in+antiestrogen-resistant+breast+cancer." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+dual+ErbB1%2FErbB2+inhibitor%2C+lapatinib+%28GW572016%29%2C+cooperates+with+tamoxifen+to+inhibit+both+cell+proliferation-+and+estrogen-dependent+gene+expression+in+antiestrogen-resistant+breast+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+dual+ErbB1%2FErbB2+inhibitor%2C+lapatinib+%28GW572016%29%2C+cooperates+with+tamoxifen+to+inhibit+both+cell+proliferation-+and+estrogen-dependent+gene+expression+in+antiestrogen-resistant+breast+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001256-Cheng1" id="pone.0001256-Cheng1"></a>Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, et al.  (1999) The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts. Embo J  18: 1571–1583.  <ul class="find" data-citedArticleID="1025270" data-doi="10.1093/emboj/18.6.1571"><li><a href="http://dx.doi.org/10.1093/emboj/18.6.1571" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+p21%28Cip1%29+and+p27%28Kip1%29+CDK+%E2%80%98inhibitors%E2%80%99+are+essential+activators+of+cyclin+D-dependent+kinases+in+murine+fibroblasts." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+p21%28Cip1%29+and+p27%28Kip1%29+CDK+%E2%80%98inhibitors%E2%80%99+are+essential+activators+of+cyclin+D-dependent+kinases+in+murine+fibroblasts.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001256-Sherr2" id="pone.0001256-Sherr2"></a>Sherr CJ (1996) Cancer cell cycles. Science (New York, NY)  274: 1672–1677.  <ul class="find" data-citedArticleID="1025318" data-doi="10.1126/science.274.5293.1672"><li><a href="http://dx.doi.org/10.1126/science.274.5293.1672" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cancer+cell+cycles." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cancer+cell+cycles.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001256-Dulic1" id="pone.0001256-Dulic1"></a>Duliâc V, Lees E, Reed SI (1992) Association of human cyclin E with a periodic G1-S phase protein kinase. Science (New York, NY)  257: 1958–1961.  <ul class="find" data-citedArticleID="1025280" data-doi="10.1126/science.1329201"><li><a href="http://dx.doi.org/10.1126/science.1329201" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Association+of+human+cyclin+E+with+a+periodic+G1-S+phase+protein+kinase." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Association+of+human+cyclin+E+with+a+periodic+G1-S+phase+protein+kinase.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001256-Osborne1" id="pone.0001256-Osborne1"></a>Osborne CK, Boldt DH, Estrada P (1984) Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. Cancer research  44: 1433–1439.  <ul class="find" data-citedArticleID="1025304"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Human+breast+cancer+cell+cycle+synchronization+by+estrogens+and+antiestrogens+in+culture.&amp;auth=&amp;atitle=Human+breast+cancer+cell+cycle+synchronization+by+estrogens+and+antiestrogens+in+culture." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Human+breast+cancer+cell+cycle+synchronization+by+estrogens+and+antiestrogens+in+culture." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Human+breast+cancer+cell+cycle+synchronization+by+estrogens+and+antiestrogens+in+culture.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001256-Brodsky1" id="pone.0001256-Brodsky1"></a>Brodsky JL, Pipas JM (1998) Polyomavirus T antigens: molecular chaperones for multiprotein complexes. J Virol  72: 5329–5334.  <ul class="find" data-citedArticleID="1025262"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Polyomavirus+T+antigens%3A+molecular+chaperones+for+multiprotein+complexes.&amp;auth=&amp;atitle=Polyomavirus+T+antigens%3A+molecular+chaperones+for+multiprotein+complexes." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Polyomavirus+T+antigens%3A+molecular+chaperones+for+multiprotein+complexes." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Polyomavirus+T+antigens%3A+molecular+chaperones+for+multiprotein+complexes.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001256-Bosco2" id="pone.0001256-Bosco2"></a>Bosco EE, Knudsen ES (2007) RB in breast cancer: at the crossroads of tumorigenesis and treatment. Cell cycle (Georgetown, Tex)  6: 667–671.  <ul class="find" data-citedArticleID="1025260" data-doi="10.4161/cc.6.6.3988"><li><a href="http://dx.doi.org/10.4161/cc.6.6.3988" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=RB+in+breast+cancer%3A+at+the+crossroads+of+tumorigenesis+and+treatment." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22RB+in+breast+cancer%3A+at+the+crossroads+of+tumorigenesis+and+treatment.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001256-Lukas1" id="pone.0001256-Lukas1"></a>Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, et al.  (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature  375: 503–506.  <ul class="find" data-citedArticleID="1025294" data-doi="10.1038/375503a0"><li><a href="http://dx.doi.org/10.1038/375503a0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Retinoblastoma-protein-dependent+cell-cycle+inhibition+by+the+tumour+suppressor+p16." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Retinoblastoma-protein-dependent+cell-cycle+inhibition+by+the+tumour+suppressor+p16.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001256-Mann1" id="pone.0001256-Mann1"></a>Mann DJ, Jones NC (1996) E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Curr Biol  6: 474–483.  <ul class="find" data-citedArticleID="1025296" data-doi="10.1016/s0960-9822(02)00515-8"><li><a href="http://dx.doi.org/10.1016/s0960-9822(02)00515-8" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=E2F-1+but+not+E2F-4+can+overcome+p16-induced+G1+cell-cycle+arrest." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22E2F-1+but+not+E2F-4+can+overcome+p16-induced+G1+cell-cycle+arrest.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0001256-Camarda1" id="pone.0001256-Camarda1"></a>Camarda G, Siepi F, Pajalunga D, Bernardini C, Rossi R, et al.  (2004) A pRb-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells. The Journal of cell biology  167: 417–423.  <ul class="find" data-citedArticleID="1025266" data-doi="10.1083/jcb.200408164"><li><a href="http://dx.doi.org/10.1083/jcb.200408164" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+pRb-independent+mechanism+preserves+the+postmitotic+state+in+terminally+differentiated+skeletal+muscle+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+pRb-independent+mechanism+preserves+the+postmitotic+state+in+terminally+differentiated+skeletal+muscle+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0001256-SantoniRugiu1" id="pone.0001256-SantoniRugiu1"></a>Santoni-Rugiu E, Falck J, Mailand N, Bartek J, Lukas J (2000) Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway. Mol Cell Biol  20: 3497–3509.  <ul class="find" data-citedArticleID="1025312" data-doi="10.1128/mcb.20.10.3497-3509.2000"><li><a href="http://dx.doi.org/10.1128/mcb.20.10.3497-3509.2000" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Involvement+of+Myc+activity+in+a+G%281%29%2FS-promoting+mechanism+parallel+to+the+pRb%2FE2F+pathway." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Involvement+of+Myc+activity+in+a+G%281%29%2FS-promoting+mechanism+parallel+to+the+pRb%2FE2F+pathway.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0001256-Sherr3" id="pone.0001256-Sherr3"></a>Sherr CJ, Roberts JM (2004) Living with or without cyclins and cyclin-dependent kinases. Genes Dev  18: 2699–2711.  <ul class="find" data-citedArticleID="1025320" data-doi="10.1101/gad.1256504"><li><a href="http://dx.doi.org/10.1101/gad.1256504" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Living+with+or+without+cyclins+and+cyclin-dependent+kinases." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Living+with+or+without+cyclins+and+cyclin-dependent+kinases.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0001256-Alevizopoulos1" id="pone.0001256-Alevizopoulos1"></a>Alevizopoulos K, Catarin B, Vlach J, Amati B (1998) A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1). Embo J  17: 5987–5997.  <ul class="find" data-citedArticleID="1025256" data-doi="10.1093/emboj/17.20.5987"><li><a href="http://dx.doi.org/10.1093/emboj/17.20.5987" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+novel+function+of+adenovirus+E1A+is+required+to+overcome+growth+arrest+by+the+CDK2+inhibitor+p27%28Kip1%29." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+novel+function+of+adenovirus+E1A+is+required+to+overcome+growth+arrest+by+the+CDK2+inhibitor+p27%28Kip1%29.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0001256-Zhang1" id="pone.0001256-Zhang1"></a>Zhang X, Wharton W, Donovan M, Coppola D, Croxton R, et al.  (2000) Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1). Molecular biology of the cell  11: 2117–2130.  <ul class="find" data-citedArticleID="1025334" data-doi="10.1091/mbc.11.6.2117"><li><a href="http://dx.doi.org/10.1091/mbc.11.6.2117" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Density-dependent+growth+inhibition+of+fibroblasts+ectopically+expressing+p27%28kip1%29." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Density-dependent+growth+inhibition+of+fibroblasts+ectopically+expressing+p27%28kip1%29.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0001256-Mukherjee1" id="pone.0001256-Mukherjee1"></a>Mukherjee S, Conrad SE (2005) c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells. J Biol Chem  280: 17617–17625.  <ul class="find" data-citedArticleID="1025302" data-doi="10.1074/jbc.m502278200"><li><a href="http://dx.doi.org/10.1074/jbc.m502278200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=c-Myc+suppresses+p21WAF1%2FCIP1+expression+during+estrogen+signaling+and+antiestrogen+resistance+in+human+breast+cancer+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22c-Myc+suppresses+p21WAF1%2FCIP1+expression+during+estrogen+signaling+and+antiestrogen+resistance+in+human+breast+cancer+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0001256-Prall2" id="pone.0001256-Prall2"></a>Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL (1998) c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol  18: 4499–4508.  <ul class="find" data-citedArticleID="1025310"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=c-Myc+or+cyclin+D1+mimics+estrogen+effects+on+cyclin+E-Cdk2+activation+and+cell+cycle+reentry.&amp;auth=&amp;atitle=c-Myc+or+cyclin+D1+mimics+estrogen+effects+on+cyclin+E-Cdk2+activation+and+cell+cycle+reentry." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=c-Myc+or+cyclin+D1+mimics+estrogen+effects+on+cyclin+E-Cdk2+activation+and+cell+cycle+reentry." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22c-Myc+or+cyclin+D1+mimics+estrogen+effects+on+cyclin+E-Cdk2+activation+and+cell+cycle+reentry.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0001256-Skildum1" id="pone.0001256-Skildum1"></a>Skildum AJ, Mukherjee S, Conrad SE (2002) The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells. J Biol Chem  277: 5145–5152.  <ul class="find" data-citedArticleID="1025322" data-doi="10.1074/jbc.m109179200"><li><a href="http://dx.doi.org/10.1074/jbc.m109179200" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+cyclin-dependent+kinase+inhibitor+p21WAF1%2FCip1+is+an+antiestrogen-regulated+inhibitor+of+Cdk4+in+human+breast+cancer+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+cyclin-dependent+kinase+inhibitor+p21WAF1%2FCip1+is+an+antiestrogen-regulated+inhibitor+of+Cdk4+in+human+breast+cancer+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0001256-Schulze1" id="pone.0001256-Schulze1"></a>Schulze A, Zerfass K, Spitkovsky D, Middendorp S, Bergáes J, et al.  (1995) Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci U S A  92: 11264–11268.  <ul class="find" data-citedArticleID="1025314" data-doi="10.1073/pnas.92.24.11264"><li><a href="http://dx.doi.org/10.1073/pnas.92.24.11264" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cell+cycle+regulation+of+the+cyclin+A+gene+promoter+is+mediated+by+a+variant+E2F+site." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cell+cycle+regulation+of+the+cyclin+A+gene+promoter+is+mediated+by+a+variant+E2F+site.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">37.
              </span><a name="pone.0001256-Fischer1" id="pone.0001256-Fischer1"></a>Fischer PM, Gianella-Borradori A (2005) Recent progress in the discovery and development of cyclin-dependent kinase inhibitors. Expert opinion on investigational drugs  14: 457–477.  <ul class="find" data-citedArticleID="1025282" data-doi="10.1517/13543784.14.4.457"><li><a href="http://dx.doi.org/10.1517/13543784.14.4.457" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Recent+progress+in+the+discovery+and+development+of+cyclin-dependent+kinase+inhibitors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Recent+progress+in+the+discovery+and+development+of+cyclin-dependent+kinase+inhibitors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">38.
              </span><a name="pone.0001256-Howes1" id="pone.0001256-Howes1"></a>Howes SH, Bockus BJ, Schaffhausen BS (1996) Genetic analysis of polyomavirus large T nuclear localization: nuclear localization is required for productive association with pRb family members. J Virol  70: 3581–3588.  <ul class="find" data-citedArticleID="1025286"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Genetic+analysis+of+polyomavirus+large+T+nuclear+localization%3A+nuclear+localization+is+required+for+productive+association+with+pRb+family+members.&amp;auth=&amp;atitle=Genetic+analysis+of+polyomavirus+large+T+nuclear+localization%3A+nuclear+localization+is+required+for+productive+association+with+pRb+family+members." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Genetic+analysis+of+polyomavirus+large+T+nuclear+localization%3A+nuclear+localization+is+required+for+productive+association+with+pRb+family+members." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Genetic+analysis+of+polyomavirus+large+T+nuclear+localization%3A+nuclear+localization+is+required+for+productive+association+with+pRb+family+members.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">39.
              </span><a name="pone.0001256-Varma2" id="pone.0001256-Varma2"></a>Varma H, Conrad SE (2002) Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling. Cancer Res  62: 3985–3991.  <ul class="find" data-citedArticleID="1025330"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Antiestrogen+ICI+182%2C780+decreases+proliferation+of+insulin-like+growth+factor+I+%28IGF-I%29-treated+MCF-7+cells+without+inhibiting+IGF-I+signaling.&amp;auth=&amp;atitle=Antiestrogen+ICI+182%2C780+decreases+proliferation+of+insulin-like+growth+factor+I+%28IGF-I%29-treated+MCF-7+cells+without+inhibiting+IGF-I+signaling." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Antiestrogen+ICI+182%2C780+decreases+proliferation+of+insulin-like+growth+factor+I+%28IGF-I%29-treated+MCF-7+cells+without+inhibiting+IGF-I+signaling." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Antiestrogen+ICI+182%2C780+decreases+proliferation+of+insulin-like+growth+factor+I+%28IGF-I%29-treated+MCF-7+cells+without+inhibiting+IGF-I+signaling.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">40.
              </span><a name="pone.0001256-Matsushime1" id="pone.0001256-Matsushime1"></a>Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, et al.  (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol  14: 2066–2076.  <ul class="find" data-citedArticleID="1025298"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=D-type+cyclin-dependent+kinase+activity+in+mammalian+cells.&amp;auth=&amp;atitle=D-type+cyclin-dependent+kinase+activity+in+mammalian+cells." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=D-type+cyclin-dependent+kinase+activity+in+mammalian+cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22D-type+cyclin-dependent+kinase+activity+in+mammalian+cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.XML" value="86010"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.PDF" value="257260"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g001.PNG_L" value="154383"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g001.PNG_M" value="52045"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g001.PNG_S" value="15641"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g001.TIF" value="278650"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g001.PNG_I" value="72571"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g002.PNG_L" value="2489009"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g002.PNG_M" value="218781"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g002.PNG_S" value="11804"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g002.TIF" value="3117500"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g002.PNG_I" value="86592"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g003.PNG_L" value="405909"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g003.PNG_M" value="99587"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g003.PNG_S" value="19904"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g003.TIF" value="604042"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g003.PNG_I" value="128276"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g004.PNG_L" value="282325"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g004.PNG_M" value="91529"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g004.PNG_S" value="15399"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g004.TIF" value="463464"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g004.PNG_I" value="77342"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g005.PNG_L" value="11701"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g005.PNG_M" value="38938"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g005.PNG_S" value="10940"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g005.TIF" value="33016"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.g005.PNG_I" value="41834"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.s001.EPS" value="647547"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001256.s002.EPS" value="1225386"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001256&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001256" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001256&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001256&volume=&issue=&title=Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells&author_name=Hemant%20Varma%2C%20Andrew%20J.%20Skildum%2C%20Susan%20E.%20Conrad&start_page=1&end_page=8" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001256" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001256" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001256" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001256&amp;t=Functional%20Ablation%20of%20pRb%20Activates%20Cdk2%20and%20Causes%20Antiestrogen%20Resistance%20in%20Human%20Breast%20Cancer%20Cells" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001256&title=Functional%20Ablation%20of%20pRb%20Activates%20Cdk2%20and%20Causes%20Antiestrogen%20Resistance%20in%20Human%20Breast%20Cancer%20Cells&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001256&amp;title=Functional%20Ablation%20of%20pRb%20Activates%20Cdk2%20and%20Causes%20Antiestrogen%20Resistance%20in%20Human%20Breast%20Cancer%20Cells" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001256" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001256&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001256';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Functional%20Ablation%20of%20pRb%20Activates%20Cdk2%20and%20Causes%20Antiestrogen%20Resistance%20in%20Human%20Breast%20Cancer%20Cells http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001256" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001256" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">








          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Breast+cancer%22" title="Search for articles in the subject area:'Breast cancer'"><div class="flagText">Breast cancer</div></a>
              <div data-categoryid="18763" data-articleid="25344"
                   data-categoryname="Breast cancer"
                   class="flagImage" title="Flag 'Breast cancer' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cancer+treatment%22" title="Search for articles in the subject area:'Cancer treatment'"><div class="flagText">Cancer treatment</div></a>
              <div data-categoryid="20025" data-articleid="25344"
                   data-categoryname="Cancer treatment"
                   class="flagImage" title="Flag 'Cancer treatment' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cell+cycle+and+cell+division%22" title="Search for articles in the subject area:'Cell cycle and cell division'"><div class="flagText">Cell cycle and cell division</div></a>
              <div data-categoryid="17353" data-articleid="25344"
                   data-categoryname="Cell cycle and cell division"
                   class="flagImage" title="Flag 'Cell cycle and cell division' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cell+cycle+inhibitors%22" title="Search for articles in the subject area:'Cell cycle inhibitors'"><div class="flagText">Cell cycle inhibitors</div></a>
              <div data-categoryid="21725" data-articleid="25344"
                   data-categoryname="Cell cycle inhibitors"
                   class="flagImage" title="Flag 'Cell cycle inhibitors' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cyclins%22" title="Search for articles in the subject area:'Cyclins'"><div class="flagText">Cyclins</div></a>
              <div data-categoryid="22357" data-articleid="25344"
                   data-categoryname="Cyclins"
                   class="flagImage" title="Flag 'Cyclins' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Estrogens%22" title="Search for articles in the subject area:'Estrogens'"><div class="flagText">Estrogens</div></a>
              <div data-categoryid="23261" data-articleid="25344"
                   data-categoryname="Estrogens"
                   class="flagImage" title="Flag 'Estrogens' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Immunofluorescence%22" title="Search for articles in the subject area:'Immunofluorescence'"><div class="flagText">Immunofluorescence</div></a>
              <div data-categoryid="19315" data-articleid="25344"
                   data-categoryname="Immunofluorescence"
                   class="flagImage" title="Flag 'Immunofluorescence' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Synthesis+phase%22" title="Search for articles in the subject area:'Synthesis phase'"><div class="flagText">Synthesis phase</div></a>
              <div data-categoryid="19095" data-articleid="25344"
                   data-categoryname="Synthesis phase"
                   class="flagImage" title="Flag 'Synthesis phase' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=1196'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=9223'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=5922&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
